--- title: Tigermed EMEA Articles | Tigermed EMEA --- [![Tigermed](https://tigermedemea.com/hs-fs/hubfs/Master%20logo.png?width=200&name=Master%20logo.png "Tigermed")](https://tigermedemea.com) - [Home](https://tigermedemea.com) - [Solutions](https://tigermedemea.com/solutions) - [Services](https://tigermedemea.com/services) - [Careers](https://tigermedemea.com/careers) - [About](https://tigermedemea.com/about) - [Blog](https://tigermedemea.com/blog) - [Contact](https://tigermedemea.com/contact) # Latest Updates ![Innovation in Immunology Is Redefining Clinical Development: Challenges and Opportunities for Clinical Trial Sponsors](https://tigermedemea.com/hubfs/IMUNOLOGIE.png) July 23, 2026 ## [Innovation in Immunology Is Redefining Clinical Development: Challenges and Opportunities for Clinical Trial Sponsors](https://tigermedemea.com/blog/innovation-in-immunology-is-redefining-clinical-development-challenges-and-opportunities-for-clinical-trial-sponsors) [In recent years, immunology has become one of the most dynamic fields in biomedical research. Advances in our understanding of the immune system have accelerated the development of therapies that,...](https://tigermedemea.com/blog/innovation-in-immunology-is-redefining-clinical-development-challenges-and-opportunities-for-clinical-trial-sponsors) [Read More](https://tigermedemea.com/blog/innovation-in-immunology-is-redefining-clinical-development-challenges-and-opportunities-for-clinical-trial-sponsors) - [All](https://tigermedemea.com/blog) - [#tigermedemea#tigermed](https://tigermedemea.com/blog/topic/tigermedemeatigermed) --- [![](https://tigermedemea.com/hubfs/IMUNOLOGIE.png)](https://tigermedemea.com/blog/innovation-in-immunology-is-redefining-clinical-development-challenges-and-opportunities-for-clinical-trial-sponsors) July 23, 2026 ## [Innovation in Immunology Is Redefining Clinical Development: Challenges and Opportunities for Clinical Trial Sponsors](https://tigermedemea.com/blog/innovation-in-immunology-is-redefining-clinical-development-challenges-and-opportunities-for-clinical-trial-sponsors) [In recent years, immunology has become one of the most dynamic fields in biomedical research....](https://tigermedemea.com/blog/innovation-in-immunology-is-redefining-clinical-development-challenges-and-opportunities-for-clinical-trial-sponsors) [Read More](https://tigermedemea.com/blog/innovation-in-immunology-is-redefining-clinical-development-challenges-and-opportunities-for-clinical-trial-sponsors) [![](https://tigermedemea.com/hubfs/blog2-1.png)](https://tigermedemea.com/blog/decentralized-clinical-trials-dct-what-remains-after-the-hype) May 7, 2026 ## [Decentralized Clinical Trials (DCT): What Remains After the Hype?](https://tigermedemea.com/blog/decentralized-clinical-trials-dct-what-remains-after-the-hype) [During the pandemic years, Decentralized Clinical Trials (DCTs) were presented as the inevitable...](https://tigermedemea.com/blog/decentralized-clinical-trials-dct-what-remains-after-the-hype) [Read More](https://tigermedemea.com/blog/decentralized-clinical-trials-dct-what-remains-after-the-hype) [![](https://tigermedemea.com/hubfs/ai2.png)](https://tigermedemea.com/blog/stricter-regulations-for-medical-ai-challenge-or-catalyst-for-innovation) March 27, 2026 ## [Stricter Regulations for Medical AI: Challenge or Catalyst for Innovation?](https://tigermedemea.com/blog/stricter-regulations-for-medical-ai-challenge-or-catalyst-for-innovation) [Artificial Intelligence is rapidly transforming healthcare—from diagnostics and imaging to clinical...](https://tigermedemea.com/blog/stricter-regulations-for-medical-ai-challenge-or-catalyst-for-innovation) [Read More](https://tigermedemea.com/blog/stricter-regulations-for-medical-ai-challenge-or-catalyst-for-innovation) [![](https://tigermedemea.com/hubfs/inima2.jpg)](https://tigermedemea.com/blog/paradigm-shifts-in-cardiology-new-aha/acc-and-esc-guidelines-and-their-impact-on-clinical-research) March 25, 2026 ## [Paradigm Shifts in Cardiology: New AHA/ACC and ESC Guidelines and Their Impact on Clinical Research](https://tigermedemea.com/blog/paradigm-shifts-in-cardiology-new-aha/acc-and-esc-guidelines-and-their-impact-on-clinical-research) [Read More](https://tigermedemea.com/blog/paradigm-shifts-in-cardiology-new-aha/acc-and-esc-guidelines-and-their-impact-on-clinical-research) [![](https://tigermedemea.com/hubfs/DIABET%202.png)](https://tigermedemea.com/blog/a-new-era-in-metabolic-therapies-accelerating-the-development-of-next-generation-treatments-for-diabetes-and-obesity) March 23, 2026 ## [A New Era in Metabolic Therapies: Accelerating the Development of Next-Generation Treatments for Diabetes and Obesity](https://tigermedemea.com/blog/a-new-era-in-metabolic-therapies-accelerating-the-development-of-next-generation-treatments-for-diabetes-and-obesity) [Diabetes and obesity are no longer viewed as isolated conditions, but rather as profound,...](https://tigermedemea.com/blog/a-new-era-in-metabolic-therapies-accelerating-the-development-of-next-generation-treatments-for-diabetes-and-obesity) [Read More](https://tigermedemea.com/blog/a-new-era-in-metabolic-therapies-accelerating-the-development-of-next-generation-treatments-for-diabetes-and-obesity) [![](https://tigermedemea.com/hubfs/FLAG.png)](https://tigermedemea.com/blog/why-eastern-europe-is-becoming-a-clinical-trial-hub) March 12, 2026 ## [Why Eastern Europe Is Becoming a Clinical Trial Hub](https://tigermedemea.com/blog/why-eastern-europe-is-becoming-a-clinical-trial-hub) [In recent years, Eastern Europe has rapidly emerged as a strategic destination for global clinical...](https://tigermedemea.com/blog/why-eastern-europe-is-becoming-a-clinical-trial-hub) [Read More](https://tigermedemea.com/blog/why-eastern-europe-is-becoming-a-clinical-trial-hub) [![](https://tigermedemea.com/hubfs/pac3.png)](https://tigermedemea.com/blog/patient-recruitment-strategies-that-work-in-2026) March 11, 2026 ## [Patient Recruitment Strategies That Work in 2026](https://tigermedemea.com/blog/patient-recruitment-strategies-that-work-in-2026) [Patient recruitment remains one of the biggest challenges in clinical research. Although the number...](https://tigermedemea.com/blog/patient-recruitment-strategies-that-work-in-2026) [Read More](https://tigermedemea.com/blog/patient-recruitment-strategies-that-work-in-2026) [![](https://tigermedemea.com/hubfs/geo2.png)](https://tigermedemea.com/blog/the-new-geopolitics-of-clinical-trials-why-location-now-shapes-innovation) March 4, 2026 ## [The New Geopolitics of Clinical Trials: Why Location Now Shapes Innovation](https://tigermedemea.com/blog/the-new-geopolitics-of-clinical-trials-why-location-now-shapes-innovation) [Global clinical research is no longer driven solely by science and patient needs. In 2026,...](https://tigermedemea.com/blog/the-new-geopolitics-of-clinical-trials-why-location-now-shapes-innovation) [Read More](https://tigermedemea.com/blog/the-new-geopolitics-of-clinical-trials-why-location-now-shapes-innovation) [![](https://tigermedemea.com/hubfs/renal%202.png)](https://tigermedemea.com/blog/innovation-and-progress-in-renal-cancer-clinical-trials) February 25, 2026 ## [Innovation and Progress in Renal Cancer Clinical Trials](https://tigermedemea.com/blog/innovation-and-progress-in-renal-cancer-clinical-trials) ## [**Current Perspectives and Strategic Directions for Partners Across EMEA**](https://tigermedemea.com/blog/innovation-and-progress-in-renal-cancer-clinical-trials) [Read More](https://tigermedemea.com/blog/innovation-and-progress-in-renal-cancer-clinical-trials) [![](https://tigermedemea.com/hubfs/202628.png)](https://tigermedemea.com/blog/beyond-the-device-why-the-next-medtech-blockbusters-are-platforms-not-products) February 17, 2026 ## [Beyond the Device: Why the Next MedTech "Blockbusters" Are Platforms, Not Products](https://tigermedemea.com/blog/beyond-the-device-why-the-next-medtech-blockbusters-are-platforms-not-products) [In the pharmaceutical world, the "blockbuster" concept has always been tied to the molecule. In...](https://tigermedemea.com/blog/beyond-the-device-why-the-next-medtech-blockbusters-are-platforms-not-products) [Read More](https://tigermedemea.com/blog/beyond-the-device-why-the-next-medtech-blockbusters-are-platforms-not-products) [1](https://tigermedemea.com/blog) [2](https://tigermedemea.com/blog/author/tigermed-emea/page/2) [3](https://tigermedemea.com/blog/author/tigermed-emea/page/3) [4](https://tigermedemea.com/blog/author/tigermed-emea/page/4) [5](https://tigermedemea.com/blog/author/tigermed-emea/page/5) [![Tigermed](https://tigermedemea.com/hs-fs/hubfs/Master%20logo.png?width=200&name=Master%20logo.png "Tigermed")](https://tigermedemea.com) Office: [+40 744 100 196](tel:+40744100196) Fax: [+40 256 200 353](tel:+40256200353) 10th Cozia Street 300209 Timișoara, Romania ###### Resources - [About Us](https://tigermedemea.com/about) - [Clinical Trial Services](https://tigermedemea.com/services) - [R&D Solutions](https://tigermedemea.com/solutions) - [Careers](https://tigermedemea.com/careers) - [Company Presentations](https://tigermedemea.com/presentations) ###### Useful Links - Terms and Conditions - Privacy Policy - [Complaints](mailto:complaints@tigermedemea.com) © 2026. Tigermed EMEA. All rights reserved ```json { "@context" : "http://schema.org", "@type" : "Corporation", "address" : { "@type" : "PostalAddress", "addressCountry" : "Romania", "addressLocality" : "Timisoara", "addressRegion" : "Timis", "postalCode" : "300209", "streetAddress" : "Cozia 10 " }, "alternateName" : "tigermedemea", "description" : "", "email" : "", "image" : "", "logo" : "https://47781279.fs1.hubspotusercontent-na1.net/hubfs/47781279/Master%20logo.png", "mainEntityOfPage" : { "@id" : "https://tigermedemea.com/blog/author/tigermed-emea/page/1", "@type" : "WebPage", "description" : "" }, "name" : "Tigermed EMEA", "sameAs" : [ "https://www.linkedin.com/company/revivalpixel/", "https://www.linkedin.com/company/revivalpixel/", "https://www.linkedin.com/company/revivalpixel/" ], "telephone" : "", "url" : "/" } ```